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Staphylococcus aureus is a Gram-positive bacterium that is present in the human
microbiota. Nevertheless, these bacteria can be pathogenic to the humans. Due to
the increasing occurrence of antibiotic-resistant S. aureus strains, new approaches to
control this pathogen are necessary. The antimicrobial photodynamic inactivation (PDI)
process is based in the combined use of light, oxygen, and an intermediary agent
(a photosensitizer). These three components interact to generate cytotoxic reactive
oxygen species that irreversibly damage vital constituents of the microbial cells and
ultimately lead to cell death. Although PDI is being shown to be a promising alternative
to the antibiotic approach for the inactivation of pathogenic microorganisms, information
on effects of photosensitization on particular virulence factors is strikingly scarce. The
objective of this work was to evaluate the effect of PDI on virulence factors of S. aureus
and to assess the potential development of resistance of this bacterium as well as
the recovery of the expression of the virulence factors after successive PDI cycles.
For this, the photosensitizer 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-
iodide (Tetra-Py+-Me) and six strains of S. aureus [one reference strain, one strain
with one enterotoxin, two strains with three enterotoxins and two methicillin resistant
strains (MRSA) – one with five enterotoxins and the other without enterotoxins] were
used. The effect of photosensitization on catalase activity, beta hemolysis, lipases,
thermonuclease, enterotoxins, coagulase production, and resistance/susceptibility to
methicillin was tested. To assess the development of resistance after successive cycles
of treatment, three strains of S. aureus (ATCC 6538, 2065 MA, and SA 3 MRSA)
were used. The surviving colonies of a first cycle of PDI were collected from the solid
medium and subjected to further nine consecutive cycles of PDI. The results indicate
that the expression of some external virulence factors is affected by PDI and enterotoxin
producing strains were more susceptible to PDI than non-toxigenic strains. The surviving
bacteria did not develop resistance. PDI, contrarily to traditional antibiotics, inhibited
the expression of virulence factors, efficiently inactivating either highly virulent strains
and low virulent S. aureus strains, inactivating also antibiotic susceptible and resistant
strains, without development of photoresistance after at least 10 consecutive cycles of
treatment, and so this therapy may become a strong promising alternative to antibiotics
to control pathogenic microorganisms.
Keywords: Staphylococcus aureus, photodynamic inactivation (PDI), virulence factors, coagulase, enterotoxins,
antibiotic/methicillin resistance
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INTRODUCTION
Staphylococcus aureus is a Gram-positive bacterium that resides
on the surface of the skin and on mucous membranes of warm-
blooded animals (Morikawa et al., 2001; Costa A.R. et al., 2013)
as a commensal microorganism, asymptomatically colonizing the
host (Bronner et al., 2004). Nevertheless, due to its invasiveness
and taking advantage of host immune weaknesses, S. aureus is
able to cause a wide spectrum of infections affecting different
organs (Bronner et al., 2004; Baptista et al., 2015), from infections
of superficial lesions to intoxications and life threatening systemic
conditions (Bien et al., 2011). This opportunistic bacterium is
a major human pathogen not only associated with community-
acquired bacteremia but also nosocomial bacteremia (Morikawa
et al., 2001; Cheung et al., 2004; Bien et al., 2011), being readily
able to acquire antibiotic resistance (Morikawa et al., 2001).
Its ability to survive under stressful conditions, such as those
imposed by host immune system, is due to the activation of
stress response mechanisms (Morikawa et al., 2001; Bronner
et al., 2004; Cheung et al., 2004). These mechanisms involve
the action of an interactive regulatory network that includes
the accessory gene regulator (agr) and staphylococcal accessory
element (sae) (Bronner et al., 2004; Novick and Geisinger, 2008;
Costa A.R. et al., 2013). These two components of the regulatory
system regulate the expression of several exoproteins and cell
wall-associated proteins related to virulence (Costa A.R. et al.,
2013). The regulatory network also includes the staphylococcal
accessory regulator A (sarA) and its homologs that regulate the
expression of some virulence factors; the sigma factors (σ), as
the primary sigma factor, σA, that may function in living process
through the housekeeping genes expression and the alternative
sigma factor σB, which may participate on the bacterial response
to stress conditions by regulating the expression of several genes
involved on stress response (Morikawa et al., 2001; Cheung et al.,
2004; Costa A.R. et al., 2013).
The S. aureus pathogenicity involves a wide array of cell
wall and extracellular components orderly expressed during
the different stages of infection: colonization, avoidance, or
invasion of the host immune defense, growth, and cellular
division culminating in bacterial dissemination, causing toxic
effects to the host (Cheung et al., 2004; Bien et al., 2011; Costa
A.R. et al., 2013; Ebrahimi et al., 2014). Some of the cell wall
components are responsible for the recognition of adhesive
matrix molecules, such as the clumping factor proteins (Clf) that
mediates the adherence to fibrinogen (Costa A.R. et al., 2013) and
the carotenoid pigment staphyloxanthin that acts as virulence
factor once it is able to perform an antioxidant action against
oxidant-based reactions (Clauditz et al., 2006; Liu and Nizet,
2009; Costa A.R. et al., 2013). The extracellular components
include the superantigen molecules such as the staphylococcal
enterotoxins (SE), a family of a single chain proteins with small
molecular-weight (24–30 kDa; Johnson et al., 1991; Baptista et al.,
2015); the cytolytic β-hemolysin, the clotting factor coagulase,
besides more exoenzymes as lipases and nucleases, in which
their main function is to disrupt the host cells/tissue and the
inactivation of host immune mechanisms of defense (Costa A.R.
et al., 2013).
Additionally to the virulence factors already described,
S. aureus has a notorious capacity to acquire antibiotic resistance
(Guillemot, 1999; Morikawa et al., 2001; Ito et al., 2003; Chambers
and DeLeo, 2009; Costa A.R. et al., 2013; Theuretzbacher, 2013),
by a bacterial gene mutation and horizontal transfer of resistance
genes from external sources (Ito et al., 2003; Chambers and
DeLeo, 2009). The resistance to penicillin emerged in the mid-
1940s, only a few years after the introduction of this antibiotic
in the clinical practice (Chambers and DeLeo, 2009; Costa
A.R. et al., 2013). Later, in 1959, the semi-synthetic antibiotic
methicillin was introduced for the treatment of infections caused
by penicillin-resistant S. aureus (Enright et al., 2002; Costa
A.R. et al., 2013). Yet, in 1961 the first cases of methicillin-
resistant S. aureus (MRSA) isolates (Chambers and DeLeo, 2009;
Costa A.R. et al., 2013) were reported and currently, only few
compounds are still effective in the treatment of MRSA infections
(Chambers and DeLeo, 2009; Theuretzbacher, 2011).
With the knowledge that the development of new classic
antibiotics is not likely to solve the resistance drug problem
for too long (Chambers and DeLeo, 2009), non-traditional
antimicrobial approaches to treat MRSA infections will be
needed. Ideally, the new antimicrobial methods should be non-
invasive and non-toxic to the hosts, but efficient and with
fast action, avoiding the development of resistance (Calin and
Parasca, 2009; Kossakowska et al., 2013; Alves et al., 2014;
Almeida et al., 2015). In this context, the photodynamic
inactivation (PDI) arises as a photo chemotherapeutic approach
with forthcoming applications as antimicrobial therapy (Almeida
et al., 2009, 2015; Carvalho et al., 2009; Costa et al., 2012; Alves
et al., 2013, 2014, 2015b; Melo et al., 2013). This technology has
already proved to be effective against Gram-positive and Gram-
negative bacteria, viruses, fungi, and parasites (Almeida et al.,
2011, 2015; Costa et al., 2012). The photodynamic effect is based
on the use of visible light and an agent (photosensitizer, PS)
capable to absorb energy from light and transfer it to molecular
oxygen, originating highly cytotoxic species, namely reactive
oxygen species (ROS) as singlet oxygen (1O2), hydrogen peroxide
(H2O2), peroxide anion radical (O•−2 ), and hydroxyl radical
(OH•; Alves et al., 2008, 2013, 2014; Calin and Parasca, 2009;
Melo et al., 2013). These reactive cytotoxic species can cause
irreversible damages to molecular cell constituents or even its
destruction (Alves et al., 2014). Initially, the PS adheres to the
microbial external structures and later, during the irradiation
process, the PDI is initiated and cellular components, such as
proteins and lipids will be exposed to oxidizing reactions which
will alter their structure and, subsequently, affect the biological
function in which they are involved (Alves et al., 2014).
As PDI acts via ROS, a high number of microbial targets
are simultaneously affected, thus preventing the development of
resistance (Costa et al., 2008; Tavares et al., 2010), and allowing
the inactivation of a broad-spectrum of microorganisms,
independently of their resistance profiles to classic antimicrobials
(Tavares et al., 2010; Arrojado et al., 2011; Costa et al., 2011;
Almeida et al., 2014). In addition, PDI affects the expression of
virulence factors, also causing their degradation (Kömerik et al.,
2000; Tubby et al., 2009; Kossakowska et al., 2013). The effects of
PDI on virulence factors is of extreme importance as they may be
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present during the infection process, when the microorganism is
present, but they can also be present when the microorganism is
not present already, such as in the case of intoxications, causing
severe damage to the host.
Clinical trials using light based therapies to evaluate the
potential use of photodynamic therapy in the clinical field
have been conducted along the last years, with positive results,
including studies against viral infections, such as the ones
caused by human papilloma virus, with systemic and topical
applications (Bujia et al., 1993; Shikowitz et al., 1998) and to
treat herpes simplex lesions, with topical applications (Moore
et al., 1972). Non-viral infections by Propionibacterium acnes, a
natural porphyrin producer, were already efficiently inactivated
(Kawada et al., 2002; Elman et al., 2003), among others, as
acne vulgaris (Ormond and Freeman, 2013). Nowadays the
miniaturization of the light devices such as low-power lasers,
light emitting diodes, or conventional lamps able to activate the
antimicrobial molecules place this technology closer to be use
in clinical application. Superficial skin infections like wounds
and burns can be easily treated (Ebrahimi et al., 2014). Using
fiber-optic technology, most regions of the anatomy are also
accessible. Loci of infection could be managed endoscopically,
allowing local application both of the PS agent and light (Dai
et al., 2010; Kharkwal et al., 2011). Even for deep-seated infections
a transcutaneous needle could deliver both drug and light via
fibers.
Some in vitro studies showed that the biological activity of
lipopolysaccharides from Escherichia coli and proteases from
Pseudomonas aeruginosa were successfully reduced by toluidine
blue (TBO)-mediated PDI (Tubby et al., 2009). Additionally,
light-activated methylene blue (MB) showed to inhibit the
expression of staphylococcal V8 protease, alpha-hemolysin and
sphingomyelinase (Tubby et al., 2009). However, the information
about the effects of PDI on virulence factor is still scarce.
The objectives of this work were the evaluation of the effect
of PDI on some virulence factors of S. aureus – catalase
activity, beta hemolysis, lipases, thermonuclease, enterotoxins,
coagulase – and the assessment of development of resistance
to PDI treatment. For that, a cationic porphyrin 5,10,15,20-
tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-
Py+-Me) was used as PS against on six S. aureus strains – ATCC
6538, 2153 MA, 2065 MA, 2095 M1A1, DSM 25693 MRSA, and
SA 3 MRSA.
MATERIALS AND METHODS
Experimental Design
An experimental procedure was established in order to study
the effects of PDI on some virulence factors expression/activity
of S. aureus strains and to test the potential development
of resistance to PDI by S. aureus strains after successive
photodynamic cycles of treatment, testing also the recovery
of the expression/activity of the virulence factors after the
successive photodynamic cycles of treatment. Six different strains
of S. aureus, including methicillin resistant and susceptible
strains, as well as, enterotoxin and non-enterotoxin producing
strains were tested. The effect of PDI on the expression/activity
of virulence factors was tested in all strains. The potential
development of resistance to PDI and the recovery of the
expression/activity of the virulence factors after the successive
cycles of treatment were tested only in three of the strains. For
each of these three strains, a total of ten cycles of treatments were
performed.
Characterization of Bacterial Strains and
Culture Conditions
Six strains of S. aureuswere used in this study: ATCC 6538, a non-
enterotoxic strain; 2153 MA, the only strain used that does not
ferment mannitol (Baptista et al., 2015), producing SE A; 2065
MA, with SE A, G, I, and S. aureus 2095 M1A1 with SE C, G and
I – the three strains isolated from food products and characterized
in the Centre of Biotechnology and Fine Chemistry of the Faculty
of Biotechnology of the Catholic University, Porto, Portugal;
S. aureus DSM 25693, a methicillin-resistant (MRSA) strain,
positive for SE A, C, H, G, and I; and a staphylococcal strain
isolated from a biological sample from the lower respiratory tract
of an hospitalized individual, a non-enterotoxic MRSA strain (SA
3 MRSA; Gonçalves et al., 2014).
All the strains were grown in Brain-Heart Infusion (BHI,
Liofilchem, Italy) at 37◦C for 18 h at 170 rpm, in order to
reach the stationary phase, corresponding approximately to a
concentration of 108–109 colony forming units per mL (CFU
mL−1). Before each PDI assay, a colony of S. aureus was
transferred to 30 mL of BHI and incubated as previously
described. Subsequently, an aliquot was transferred to fresh
medium, and grown in the same conditions. This procedure was
repeated twice.
Photosensitizer
The PS 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin
tetra-iodide (Tetra-Py+-Me) used in this study was prepared
according to the literature (Carvalho et al., 2010). Their 1H
NMR and UV–vis spectra were consistent with the literature data.
Their purity was confirmed by thin layer chromatography and
1H NMR. 1H NMR (DMSO-d6): -3.12 (s, 2H, NH), 4.73 (s, 12H,
CH3), 9.00 (d, J = 6.5 Hz, 8H, Py-o-H), 9.22 (s, 8H, β-H), 9.49
(d, J = 6.5 Hz, 8H, Py-m-H). UV–vis (DMSO) λmax (log ε): 425
(5.43), 516 (4.29), 549 (3.77), 588 (3.84), 642 (3.30) nm. The stock
solutions (500 µM) of this porphyrin were prepared using the
polar aprotic solvent dimethyl sulfoxide (DMSO).
Antimicrobial Photodynamic Therapy
(PDI) Treatments
Bacterial cultures in stationary phase were 10-fold diluted in
phosphate buffered saline (PBS) and this bacterial suspension was
distributed in sterilized glass beakers. The appropriate quantity of
the PS Tetra-Py+-Me was added to achieve a final concentration
of 5.0 µM. The total volume of final solution was 10 mL per
beaker. During the experiments, light and dark controls were
also performed: in the light control the beaker without Tetra-
Py+-Me was exposed to light; in the dark control the beaker
containing 5.0 µM Tetra-Py+-Me was protected from light with
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aluminum foil during the experiment. During the pre-irradiation
period, the samples were incubated for 10 min with stirring,
at room temperature, in order to promote the binding of the
porphyrin to S. aureus cells. The samples were exposed to an
artificial white light (PAR radiation, 13 OSRAM 21 lamps of
18 W each, 380–700 nm) with an irradiance of 40 W m−2 for
60 min, under stirring. During the experiment, aliquots of treated
and control samples were collected at times 0, 5, 10, 15, 30, and
60 min.
Enumeration of Viable Cells
From each treated and control samples 10-fold serial dilutions
were prepared in sterile PBS (10−1 to 10−6). Aliquots of 100 µL
were pour-plated, in duplicate, in Plate Count Agar medium
(PCA, Liofilchem, Italy). The plates were incubated at 37◦C for
48 h and the number of colonies was counted. Three independent
assays were performed.
PDI Resistance Assays
In order to verify the development of resistance to PDI treatment
with Tetra-Py+-Me, ten cycles of PDI were performed. After each
cycle of a total irradiation time of 60 min, a new set of bacterial
cultures were prepared from an isolated colony, surviving to the
previous cycle of PDI (at 37◦C, 18 h, 170 rpm). The PDI treatment
was repeated under similar conditions. Three independent assays
were performed.
Virulence Factors, Mannitol Fermentation,
and Methicillin Susceptibility
To assess if PDI treatments affected the virulence factors of
S. aureus, treated and controls samples were tested for the
presence or activity of virulence factors, according to literature
(Baptista et al., 2015). One typical colony of S. aureus was
selected from each strain. The β-hemolysin activity was detected
by streaking Blood Agar Plates (Sheep Blood 7%; BAP, Liofilchem,
Italy) and observing the development of a clear/yellow zone
surrounding S. aureus colonies. Lipase and lecithinase activities
were assessed by streaking Baird Park Agar (BPA, Liofilchem,
Italy) in which S. aureus colonies appear in black, with an
opaque precipitation zone (lipase activity) and a clear zone
surrounding it (lecithinase activity). The mannitol fermentation
was evaluated using Mannitol Salt Agar (MSA, Liofilchem, Italy),
being the positive results detected by a change of color of the
medium from pink to yellow. Catalase activity was assessed
using Catalase/Oxy Test (Liofilchem, Italy), interpreting the
formation of gas bubbles as a positive result. The activity
of bound coagulase (clumping factor) was determined using
Pastorex Staph Plus (Bio-Rad, USA) and the activity of free
coagulase was detected using BBL Coagulase Plasma Rabbit (BD,
USA). For this, 1.0 mL of supernatant of treated and non-
treated samples was collected by centrifugation at 13,000 × g for
10 min, at 4◦C, and 0.5 mL of BBL Coagulase Plasma reagent
was added and the mixture was incubated at 37◦C for 24 h.
The results were considered positive when the agglutination
occurred. The rate of clot formation was evaluated according
to the manufacturer’s instruction. Thermonuclease activity was
determined by D.N.A. Toluidine Blue Agar (Bio-Rad, USA) and
positive results were detected as a change of color of the halos
from blue to pink. The presence of SE was determined using
SET-RPLA Kit Toxin Detection Kit (Thermo Scientific, UK),
a kit based on reversed passive latex agglutination technique,
according to the manufacturer’s instruction. Treated and non-
treated samples were centrifuged at 900 × g for 20 min at 4◦C.
The presence of enterotoxins H, G, and I was not tested since
SET-RPLA Kit Toxin Detection Kit only covers SE A, B, C, and D,
which are the most common enterotoxins of S. aureus (Baptista
et al., 2015). The susceptibility to methicillin was determined
using the cefoxitin disk screen test, accordingly to the Clinical and
Laboratory Standards Institute [CLSI] (2013). Cultures with halos
≥22 mm were considered methicillin susceptible and cultures
with halos ≤21 were classified as methicillin resistant (Clinical
and Laboratory Standards Institute [CLSI], 2013). Carotenoid
pigments (staphyloxanthin) were determined using a protocol
adapted from Morikawa et al. (2001). Each strain was cultured
in BHI medium at 37◦C for 72 h. Twenty milliliters of the
culture were harvested by centrifugation (10,000 × g, 10 min)
and washed with purified water. The cells were suspended in
5.0 mL of methanol and heated in a bath at 55◦C for 15 min,
until visible pigments have been extracted. Cellular debris was
removed by centrifugation at 15,000 × g for 10 min. The
absorbance at 465 nm of the methanol extracts were measured in
a quartz cuvette in a spectrophotometer (Dynamica Halo DB-20,
UK).
The β-hemolysis, lipase and lecithinase, catalase, bound
coagulase and thermonuclease activities, mannitol fermentation
and methicillin susceptibility were tested in the PDI surviving
cells, after plating and incubation at 37◦C. Methicillin
susceptibility was inferred from the diameter of the inhibition
zone around cefoxitin disks, and the results represent the
average of the inhibition zones from three independent tests.
Free coagulase and SE A and C activities were assessed in the
supernatant of treated samples and controls after PDI assays.
The effect of PDI on the isolated toxins was also individually
assessed. Purified SE A and C (available on SET-RPLA Kit Toxin
Detection Kit as SE A and C controls) were subjected to the PDI
treatment. The concentration of the PS was the same used before:
5.0 µM; the amount of SE used was 63 µL from the reconstituted
control reagents (the kit control solution contains 25 ng of
purified enterotoxin reconstituted in 0.5 mL of diluent from the
kit as showed in Figure in section “Quantity of Enterotoxins (ng)
Per Kit” of the Supplementary Material), and PBS was added
to make up a total volume of 2.0 mL of solution, which was
irradiated. Light and dark controls were included. At times 0,
5, 10, 15, 30, and 60 min aliquots of 25 µL were collected and
the activity of the SE was tested using the SET-RPLA Kit Toxin
Detection Kit.
RESULTS
Bacterial Inactivation by PDI
Cells suspensions of S. aureus strains were subjected to 60 min
of PDI treatments (5.0 µM of Tetra-Py+-Me and an irradiance
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FIGURE 1 | Survival curves of six S. aureus strains (ATCC 6538, enterotoxic strains 2153 MA, 2095 M1A1, 2065 MA, and DSM 25693 MRSA and SA 3
MRSA) incubated with 5.0 µM of Tetra-Py+-Me and irradiated with white light (380–700 nm) with an irradiance of 40 W m−2 for 60 min. Lines
representing light (LC) and dark (DC) controls viability were omitted, since cell viability in the controls was not affected. Values represent the mean of three
independent experiments with two replicates each; error bars indicate the standard deviation.
of 40 W m−2), and aliquots were taken before (0 min) and
after 5, 10, 15, 30, and 60 min of treatment. All the strains
were efficiently inactivated by PDI (Figure 1). After 60 min of
treatment under the tested conditions reductions higher than 5
log CFU mL−1 were observed for all the tested strains. However,
in general, the pattern of photoinactivation was different among
the S. aureus strains as showed by the log10 reduction rates
(Figure 1).
The enterotoxic strains were more efficiently inactivated than
the non-enterotoxic ones. The toxigenic S. aureus strain 2095
M1A1 was particularly susceptible to PDI showing a reduction
of 7 log within the first 10 min of irradiation. With equivalent
irradiation time, the enterotoxic strain 2153 MA showed a
reduction of only 2.5 log and all the other strains were inactivated
less than 2 log. For DSM 25693 MRSA strain, also an enterotoxic,
a linear decrease was observed after 15 min of treatment, reaching
complete inactivation after 60 min of treatment (8.5 log). After
60 min of treatment, the inactivation factors for the other strains
were 5.3 log for ATCC 6538, 6.0 log for SA 3 MRSA, 6.3 log for
2065 MA, 6.3 log for 2153 MA, and 7.8 log for 2095 M1A1. In the
controls, the concentration of viable cells did not vary, indicating
that the viability of bacterial cells was neither affected by light
alone (light control), nor by the direct toxicity of the PS (dark
control).
Development of Resistance after
Repeated PDI Cycles and Recovery of
Viability Between Cycles
Three S. aureus strains (ATCC 6538, 2065 MA, and SA 3 MRSA)
were subjected to ten consecutive PDI cycles (Figure 2). The
authors decide to test 10 cycles having into account previous
results of the research group (Tavares et al., 2010; Costa et al.,
2011). The PDI efficiency of photosensitization with Tetra-Py+-
Me was not affected during the sequence of 10 PDI cycles.
Effect of PDI on S. aureus Virulence
Factors, Methicillin Susceptibility, and
Mannitol Fermentation
After each PDI assay, the activity and presence of virulence
factors, mannitol fermentation, and methicillin susceptibility
were tested (Table 1).
The surviving cells to PDI treatments retained the capacity
to express all the virulence factors and to ferment mannitol.
However, the activity of the extracellular virulence factors free
coagulase and enterotoxins, assessed in the supernatant of treated
samples, was affected (see section “Testing the Presence of Free
Coagulase” of Supplementary Material and Table 1). For the
test of free coagulase, the BBL Coagulase Plasma reagent was
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FIGURE 2 | Photodynamic inactivation efficiency of ten consecutive cycles of S. aureus ATCC 6538 (A), 2065 MA (B), and SA 3 MRSA (C) by 5.0 µM of
Tetra-Py+-Me after 60 min of irradiation with white light (40 W m−2). N0 represents the plaque counts of bacterial cells before the irradiation; N represents the
plaque counts after the cycle treatment; error bars indicate the standard deviation.
Frontiers in Microbiology | www.frontiersin.org 6 March 2016 | Volume 7 | Article 267
fmicb-07-00267 March 4, 2016 Time: 17:56 # 7
Bartolomeu et al. Effect of Photodynamic Therapy on the Virulence Factors
TABLE 1 | The activity of the virulence factors, mannitol fermentation, and susceptibility to methicillin were tested, after PDI treatments, in presence of
5.0 µM of Tetra-Py+-Me and irradiated with white light (380–700 nm) with an irradiance of 40 W m−2 for 60 min.
Staphylococcus aureus strains Samples Surviving cells Supernatant
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A C
ATCC 6538 S + + + + + + 30 – # #
LC + + + + + + 29 4+ # #
DC + + + + + + 29 4+ # #
2153 MA S + + – + + + 25 – – #
LC + + – + + + 26 3+ + #
DC + + – + + + 26 3+ + #
2065 MA S + + + + + + 28 – – #
LC + + + + + + 28 3+ + #
DC + + + + + + 28 3+ + #
2095 M1A1 S + + + + + + 27 – # –
LC + + + + + + 26 3+ # +
DC + + + + + + 27 3+ # +
DSM 25693 MRSA S + + + + + + <21 – – –
LC + + + + + + <21 3+ + +
DC + + + + + + <21 3+ + +
SA 3 MRSA S + + + + + + <21 – # #
LC + + + + + + <21 4+ # #
DC + + + + + + <21 4+ # #
These tests were performed in three independent assays for each strain. Cardinal symbol in the “Supernatant, SE” columns means that such tests have not been
performed for the respective strains once these strains do not produce the mentioned virulence factors.
added to an aliquot of supernatant and the resulting samples
was incubated for 24 h. Clot formation was not detected
in photosensitized samples. The SE test, performed in the
supernatant of photosensitized cells by the SET-RPLA Kit Toxin
Detection Kit test, revealed the formation of a tight button,
interpreted as absence of SE or presence at a concentration below
the detection limit. These two virulence factors persisted in light
and dark controls.
Susceptibility of Staphylococcal Isolated
Enterotoxins to PDI
The isolated enterotoxins A and C were directly treated by
PDI [see section “Purified SE A (A) and C (B) Subjected
to Photodynamic Treatment” of Supplementary Material and
Table 2]. The positive result corresponds to agglutination, leading
to the formation of a lattice structure and negative correspond to
the formation of a tight button, which occurs if SE are absent or
present in a concentration bellow the detection level (TD0900,
SET-RPLA, 2015). Before the treatment, enterotoxins A and C
were still detected (formation of a lattice structure). During the
PDI, the formation of the lattice structure decreases (as seen
in the first well of 15 and 30 min test, see section “Purified
SE A (A) and C (B) Subjected to Photodynamic Treatment” of
Supplementary Material) and the formation of a tight button (as
seen in the first well of 60 min test), begins to occur, indicating
the shift to a negative result. After 60 min of irradiation, the
TABLE 2 | The purified SE A and C were subjected to PDI for 60 min.
Irradiation time Isolated and purified SEs
A C
0 S + +
LC + +
DC + +
60 S – –
LC + +
DC + +
The SE activity was assessed before (0 min), during (5, 10, 15, and 30 min) and
after 60 min of treatment for treated (S) and non-treated samples (light control, LC;
dark control, DC). Three independent assays were performed.
inactivation was >68% for both SE [SE A and C; see section
“Calculating the Decrease (%) of Enterotoxins After PDI Assays”
of Supplementary Material].
Carotenoid Pigments Content
Carotenoid pigments were detected in all the tested strains.
The strains SA 3 MRSA with an absorbance at 465 nm of
0.995 ± 0.001 and the 2065 MA with an absorbance of
0.911 ± 0.017, display the highest concentration of pigments,
followed by DSM 25693 MRSA (Abs of 0.788 ± 0.021), ATCC
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6538 (Abs of 0.701 ± 0.005), 2153 MA (Abs of 0.480 ± 0.002),
and 2095 M1A1 (Abs of 0.411± 0.013).
DISCUSSION
According to literature, the susceptibility of S. aureus to PDI
is strain-dependent and MRSA strains seem to have a lower
susceptibility to PDI than methicillin-sensitive counterparts
(Grinholc et al., 2008). The lower susceptibility of MRSA strains
to PDI has been attributed to slime production by the MRSA
strains used (Grinholc et al., 2008).
In this study, all the strains tested were susceptible to PDI, with
a survival reduction above 5 log CFU mL−1, which according to
American Society of Microbiology is higher than the minimum
required (reduction > 3 log CFU mL−1) for a new approach to
be termed as antimicrobial (ASM, 2015). However, as observed
in previous studies, a strain-dependent efficiency of inactivation
was observed (Grinholc et al., 2008). Nonetheless PDI does
not seem to be antibiotic-susceptible dependent, since DSM
25693, an MRSA and enterotoxic strain, was the only strain
that was inactivated to the limit of detection of the method,
with a survival reduction of 8.5 log. Another MRSA strain, SA
3 MRSA, was not as efficiently inactivated, but the inactivation
profile was similar to that of the reference, ATCC 6538 strain.
The four enterotoxic strains were more efficiently inactivated
that the two non-enterotoxic strains (see Figure 1), which could
suggest that the enterotoxic strains are more susceptible to
PDI. However, as showing the log10 reduction rates differences
in PDI inactivation between enterotoxic strains were observed,
which means that other cell factors may contribute to these
differences in PDI efficiency. Whereby, further studies should
be performed exploiting the factors which may contribute
to the difference in PDI susceptibility among the bacterial
strain.
Carotenoid pigment content is related with the resistance of
S. aureus to several stress factors, such as external oxidative
stress. Several studies have shown that mutant strains that are
unable to produce carotenoids are more susceptible to those
stress factors (Liu et al., 2005; Clauditz et al., 2006; Cebrián
et al., 2007). In an attempt to verify if carotenoid pigments
were able to attenuate oxidative damages and consequent cellular
inactivation, the pigment content of each strain was measured.
Although a direct relation between carotenoids content and PDI
efficiency was not observed for all the strains, the least susceptible
strains to PDI (ATCC 6538 and SA 3 MRSA) show a high relative
concentration of this pigment, with absorbances of 0.701 and
0.995, respectively.
Once the photodynamic action occurs through ROS
generation (formed along the irradiation process), the damages
(through oxidative process) can affect a variety of cellular
components with great importance in the maintenance of
bacterial stability, such as molecular components (proteins
and lipids) of external structures, and enzymes (Alves et al.,
2014; Almeida et al., 2015). The majority of virulence factors of
S. aureus are proteins or enzymes that are prone to photodynamic
oxidative damage. The results of this study show that the
phenotypic expression of the of β-hemolysin, lipase, lecithinase,
catalase and bound coagulase by surviving cells cultivated
on PCA medium for 48 h at 37◦C was not affected by PDI.
Mannitol uptake and fermentation also persisted. Previous
proteomic analysis showed that the oxidative damage caused
by PDI treatment affects the expression of functional proteins
involved in cell division, metabolic activities, oxidative stress
responses, and sugar uptake (Alves et al., 2014, 2015a). However,
the mentioned studies were performed in treated cells. Since the
detection of virulence factors activity in our study was performed
in the surviving cells after a period of recovery, it would be
expected that the bacteria, even if injured during PDI treatments,
would be able to continue producing those virulence factors and
other enzymes.
Antioxidant enzymes such as superoxide dismutase, catalase,
and peroxidase can give protection against some ROS but
not against singlet oxygen. So, according to the literature
porphyrinic compounds (Almeida et al., 2011), namely the
tetracationic porphyrin Tetra-Py+-Me used in this study, exert
their photodynamic action by a type II mechanism and
consequently singlet oxygen is the main ROS (Tavares et al.,
2011; Costa L. et al., 2013). Moreover, has been shown that
singlet oxygen is able to inactivate these enzymes, namely the
catalase enzyme (Kim et al., 2001). However, no effect of the
PDI process was observed for this enzyme, once that in this
study, the catalase activity was only determined after a recovery
period of the persistent cells, and not during the PDI treatment –
condition in which could be detected some changes in the activity
of catalase. Further studies are needed to clarify whether the
ROS produced by the Tetra-Py+-Me during PDI treatments affect
catalase enzyme and even other enzymes when they are outside
the cells.
Nevertheless, some of these virulence factors are released to
the extracellular compartment, becoming more exposed to the
effects of the PDI process suffering a greater damage.
In this study, the presence/activity of two external virulence
factors (free coagulase and enterotoxins A and C) in the
supernatant of PDI treatment samples was assessed. The results
show that both virulence factors are affected by PDI. This
represents an advantage relatively to traditional antibiotics, which
act only on bacterial cell and not on extracellular virulence
factors. These results are in accordance with those observed in
the previous studies by Kömerik et al. (2000) and Tubby et al.
(2009).
The response of one of the most important S. aureus virulence
factors, the SE which are the staphylococcal food poisoning
causative agents, was also assessed after PDI treatment in order
to confirm the effect of PDI on extracellular virulence factors.
Two isolated enterotoxins, SE A and C, were treated by PDI.
The porphyrin Tetra-Py+-Me at a concentration of 5.0 µM
reduced at least in 68% the amount of active SE A and C. This
discovery is of great importance since it is known that this
family of proteins covers very stable, resistant to heat and to
degrading enzymes molecules (Schelin et al., 2011). These results
demonstrate that PDI is not only effective in the inactivation of
microorganisms but also in the degradation of released external
virulence factors.
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One of the main advantages of PDI is that because of
the nature of the photoinactivation process, development of
resistance is very unlikely (Tavares et al., 2010; Costa et al.,
2011). The results obtained in this study do not show evidence
of resistance development in the three strains subjected to
ten PDI cycles, which corroborates literature conclusions.
Considerable reduction in the efficiency of photosensitization
of S. aureus strains ATCC 6538, enterotoxic 2065 MA and
SA 3 MRSA after ten consecutive photosensitization sessions
of 60 min with 5.0 µM of Tetra-Py+-Me was not observed.
As in this study, the viable bacterial colonies have been
aseptically removed from the plate and suspended in PBS
after each PDI cycle, the cellular density obtained after the
colony resuspension could be different. To avoid differences
in the PDI efficiency due to different bacterial densities, this
parameter was controlled in all the experiments by measuring
the optical density of the bacteria suspension before each
assay.
CONCLUSION
Overall, it can be concluded that (1) although the efficiency of
PDI to inactivate S. aureus is strain-dependent, all the strains can
be effectively inactivated, namely the enterotoxic strains; (2) PDI
process is not only effective in the inactivation of microorganisms
but also in the degradation of their external virulence factors
after their release to the exterior; and (3) S. aureus strains do not
develop resistance to PDI treatment.
The research conducted so far, allowed the development
of very promising and successful in vitro photoinactivation
protocols for enterotoxigenic and non-enterotoxigenic strains
of S. aureus. However, their evaluation in vivo, along with
validation of their feasibility according to different sample
settings and different enterotoxigenic and non-enterotoxigenic
strains of S. aureus, as well as on biofilms developed by these
bacteria, are now required. Bacterial biofilms are not only more
difficult to inactivate than planktonic bacteria, but bacteria in a
biofilm-mode are also much more prone to become resistant to
antimicrobial agents or strategies (Beirão et al., 2014). In fact,
some mechanisms, such as horizontal gene transfer and quorum
sensing, occur only in a biofilm-state (Madsen et al., 2012; Solano
et al., 2014).
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